Related Experiment Video
Updated: Jun 3, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
A Bayesian Hidden Markov Model using continuous longitudinal test data: Evaluation and application to BVD detection
Aurélien Madouasse1, Matthieu Trotreau2, Grégoire Kuntz3
1Oniris, INRAE, BIOEPAR, 44300, Nantes, France.
Abstract:
This study presents a Bayesian Hidden Markov Model (HMM) that integrates continuous test results with temporal disease dynamics to improve surveillance of infectious diseases using pooled samples such as bulk tank milk (BTM). The model extends a previous HMM that relied on dichotomised results by modelling test data as mixtures of normal distributions, thereby retaining more information and improving parameter estimation. Simulations showed that the continuous HMM consistently outperformed a discrete version, with the greatest advantage in scenarios of higher infection incidence and more frequent state changes, where temporal correlation is weaker. Model performance remained robust for the estimation of dynamic parameters and diagnostic sensitivity and specificity. Applied to 2014-2020 data from the bovine viral diarrhoea virus (BVDV) surveillance programme in Brittany, France, the model estimated stable test characteristics across four départements. It confirmed the higher sensitivity of one of the two antibody ELISA tests compared the other and revealed generally low rates of transition to seropositivity and high persistence of seropositivity. Slightly higher herd-level seropositivity and distinct parameter estimates in Ille-et-Vilaine likely reflect differences in herd structure or infection dynamics. The continuous HMM provides a rigorous framework for evaluating diagnostic tests, selecting optimal thresholds, and identifying positive herds based on longitudinal data. While future improvements could include modelling covariates and addressing potential misclassification due to cross-reactions, the approach offers a robust and adaptable tool for disease surveillance and test evaluation in diverse epidemiological contexts.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Statistical Methods for Analyzing Epidemiological Data
Biostatistics: Overview
Discrete variables are...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
The...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
